Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 13/20 | 0.52 |
| ▸ | ADRB1 | P08588 | 8/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.47 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.47 |
| ▸ | HTR2A | P28223 | 1/20 | 0.47 |
| ▸ | HTR2C | P28335 | 1/20 | 0.47 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.47 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.47 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.47 |
| ▸ | DRD3 | P35462 | 1/20 | 0.47 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.47 |
| ▸ | SRSF6 | Q13247 | 1/20 | 0.47 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.47 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | HTR1A | P08908 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1221455 | 0.87 | ADRB2 (0.55) | ADRB2ADRB1SLC6A2ADRA1DHTR2A | |
| SCHEMBL1956144 | 0.82 | ADRB2 (0.71) | ADRB2ADRB1SLC6A2ADRA1DHTR2A | |
| SCHEMBL1956140 | 0.82 | ADRB2 (0.71) | ADRB2ADRB1SLC6A2ADRA1DHTR2A | |
| Hydrochloric Acid SCHEMBL1219942 | 0.82 | ADRB2 (0.69) | ADRB2ADRB1SLC6A2ADRA1DHTR2A | |
| Hydrochloric Acid SCHEMBL1219944 | 0.82 | ADRB2 (0.69) | ADRB2ADRB1SLC6A2ADRA1DHTR2A | |
| SCHEMBL30215650 | 0.82 | ADRB2 (0.71) | ADRB2ADRB1SLC6A2ADRA1DHTR2A | |
| Hydrochloric Acid SCHEMBL1221560 | 0.81 | ADRB2 (0.70) | ADRB2ADRB1SLC6A2ADRA1DHTR2A | |
| Hydrochloric Acid SCHEMBL1221558 | 0.81 | ADRB2 (0.70) | ADRB2ADRB1SLC6A2ADRA1DHTR2A | |
| Hydrochloric Acid SCHEMBL1953996 | 0.81 | ADRB2 (0.70) | ADRB2ADRB1SLC6A2ADRA1DHTR2A | |
| SCHEMBL22864090 | 0.81 | ADRB2 (0.48) | ADRB2ADRB1SLC6A2DRD3HTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220315534-A1 | BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME | CURASEN THERAPEUTICS, INC. | 2022-10-06 | — | — | US | disclosed |
| WO-2021003161-A1 | BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME | CURASEN THERAPEUTICS, INC. (US) | 2021-01-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220315534-A1 | BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME | ADRB2, ADRB1, ADRA2C | ADRB2 1/4885ADRB1 2/4885SLC6A2 55/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.